NCT00633074View on ClinicalTrials.gov

Non-inferiority Study of GSK Biologicals' Influenza Vaccine GSK576389A Using Different Formulations

PHASE2CompletedINTERVENTIONAL
Enrollment

720

Participants

Timeline

Start Date

March 3, 2008

Primary Completion Date

April 11, 2008

Study Completion Date

April 11, 2008

Conditions
Influenza
Interventions
BIOLOGICAL

Thiomersal-free FluAS25 adjuvanted vaccine (GSK576389A)

Intramuscular administration, 1 dose

BIOLOGICAL

Thiomersal reduced FluAS25 adjuvanted vaccine (GSK576389A)

Intramuscular administration, 1 dose

Trial Locations (3)

13419

GSK Investigational Site, Tallinn

50417

GSK Investigational Site, Tartu

75501

GSK Investigational Site, Saku

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY